(Q45405213)

English

Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.

scientific article published on 11 April 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Simian immunodeficiency virus

0 references

David I Watkins

9

object named as

David I Watkins

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Deborah Heydenburg Fuller

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tim Shipley

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Todd M Allen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

James T Fuller

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Mary S Wu

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Helen Horton

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Nancy Wilson

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Georg Widera

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David I Watkins

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

11 April 2007

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

364

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

245-255

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Independence of granzyme B secretion and interferon- gamma production during acute simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

A poliovirus neutralization epitope expressed on hybrid hepatitis B surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Improved Humoral and Cellular Immune Responses Against the gp120 V3 Loop of HIV-1 Following Genetic Immunization with a Chimeric DNA Vaccine Encoding the V3 Inserted into the Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

A high frequency of Mamu-A*01 in the rhesus macaque detected by polymerase chain reaction with sequence-specific primers and direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in Balb/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Cellular immune responses to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Induction of anti-human immunodeficiency virus (HIV) neutralizing antibodies in rabbits immunized with recombinant HIV--hepatitis B surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

T- and B-cell recognition of hepatitis B viral antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

The hepatitis nucleocapsid as a vaccine carrier moiety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Role of B cells in antigen presentation of the hepatitis B core

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Th1 versus Th2 responses in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Hepatitis B virus core particles as a vaccine carrier moiety

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.02.024

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen processing in vivo and the elicitation of primary CTL responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Core particles of hepatitis B virus as carrier for foreign epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

lck-independent inhibition of T cell antigen response by the HIV gp120

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17428516

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VIROL.2007.02.024

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428516%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45405213&oldid=1398855453"